A Phase 1, Randomized, Double-Blinded, Placebo-Controlled, Single Center Trial to Assess the Safety, Tolerability, and Pharmacokinetics of AV411 in Healthy Subjects
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Ibudilast (Primary)
- Indications Alcoholism; Allergic conjunctivitis; Amyotrophic lateral sclerosis; Asthma; Cerebrovascular disorders; Multiple sclerosis; Opioid-related disorders; Substance-related disorders
- Focus Adverse reactions
- Sponsors Avigen
- 17 Jun 2016 New trial record